A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial

Publication | Open Access

DOI Full Paper Access

117

Citations

References

2017

Year

Nick Battersby, Mit Dattani, Sheela Rao, David Cunningham, Diana Tait, Richard Adams, Brendan Moran, Shelize Khakoo, Paris Tekkis, Shahnawaz Rasheed,

Trials

Abstract

References